vs

Side-by-side financial comparison of ASTRONICS CORP (ATRO) and CareTrust REIT, Inc. (CTRE). Click either name above to swap in a different company.

ASTRONICS CORP is the larger business by last-quarter revenue ($240.1M vs $134.9M, roughly 1.8× CareTrust REIT, Inc.). On growth, CareTrust REIT, Inc. posted the faster year-over-year revenue change (55.1% vs 15.1%). Over the past eight quarters, CareTrust REIT, Inc.'s revenue compounded faster (46.2% CAGR vs 13.9%).

Astronics Corporation is an American aerospace electronics corporation founded in 1968, headquartered in East Aurora, New York. It is traded on NASDAQ as Nasdaq: ATRO. It is known for lighting and electronics integrations on military, commercial, and business aircraft and semiconductor test systems.

Target Healthcare REIT is a British property investment company which invests in healthcare properties and holds a large portfolio of care homes. It is structured as a real estate investment trust (REIT) and is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.

ATRO vs CTRE — Head-to-Head

Bigger by revenue
ATRO
ATRO
1.8× larger
ATRO
$240.1M
$134.9M
CTRE
Growing faster (revenue YoY)
CTRE
CTRE
+40.0% gap
CTRE
55.1%
15.1%
ATRO
Faster 2-yr revenue CAGR
CTRE
CTRE
Annualised
CTRE
46.2%
13.9%
ATRO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ATRO
ATRO
CTRE
CTRE
Revenue
$240.1M
$134.9M
Net Profit
$111.3M
Gross Margin
33.3%
Operating Margin
14.8%
Net Margin
82.5%
Revenue YoY
15.1%
55.1%
Net Profit YoY
113.5%
EPS (diluted)
$0.82
$0.52

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ATRO
ATRO
CTRE
CTRE
Q4 25
$240.1M
$134.9M
Q3 25
$211.4M
$132.4M
Q2 25
$204.7M
$112.5M
Q1 25
$205.9M
$96.6M
Q4 24
$208.5M
$86.9M
Q3 24
$203.7M
$77.4M
Q2 24
$198.1M
$68.9M
Q1 24
$185.1M
$63.1M
Net Profit
ATRO
ATRO
CTRE
CTRE
Q4 25
$111.3M
Q3 25
$-11.1M
$74.9M
Q2 25
$1.3M
$68.5M
Q1 25
$9.5M
$65.8M
Q4 24
$52.1M
Q3 24
$-11.7M
$33.4M
Q2 24
$1.5M
$10.8M
Q1 24
$-3.2M
$28.7M
Gross Margin
ATRO
ATRO
CTRE
CTRE
Q4 25
33.3%
Q3 25
30.5%
Q2 25
25.8%
Q1 25
29.5%
Q4 24
29.8%
Q3 24
27.1%
Q2 24
28.0%
Q1 24
25.7%
Operating Margin
ATRO
ATRO
CTRE
CTRE
Q4 25
14.8%
Q3 25
10.9%
58.1%
Q2 25
2.3%
61.3%
Q1 25
6.4%
Q4 24
4.3%
Q3 24
4.1%
43.0%
Q2 24
3.8%
15.1%
Q1 24
0.9%
Net Margin
ATRO
ATRO
CTRE
CTRE
Q4 25
82.5%
Q3 25
-5.2%
56.6%
Q2 25
0.6%
60.9%
Q1 25
4.6%
68.1%
Q4 24
60.0%
Q3 24
-5.8%
43.2%
Q2 24
0.8%
15.6%
Q1 24
-1.7%
45.6%
EPS (diluted)
ATRO
ATRO
CTRE
CTRE
Q4 25
$0.82
$0.52
Q3 25
$-0.31
$0.35
Q2 25
$0.04
$0.35
Q1 25
$0.26
$0.35
Q4 24
$-0.07
$0.30
Q3 24
$-0.34
$0.21
Q2 24
$0.04
$0.07
Q1 24
$-0.09
$0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ATRO
ATRO
CTRE
CTRE
Cash + ST InvestmentsLiquidity on hand
$18.2M
$198.0M
Total DebtLower is stronger
$894.2M
Stockholders' EquityBook value
$140.1M
$4.0B
Total Assets
$706.7M
$5.1B
Debt / EquityLower = less leverage
0.22×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ATRO
ATRO
CTRE
CTRE
Q4 25
$18.2M
$198.0M
Q3 25
$13.5M
$712.5M
Q2 25
$13.5M
$306.1M
Q1 25
$24.8M
$26.5M
Q4 24
$9.3M
$213.8M
Q3 24
$5.2M
$377.1M
Q2 24
$2.9M
$495.1M
Q1 24
$5.3M
$451.2M
Total Debt
ATRO
ATRO
CTRE
CTRE
Q4 25
$894.2M
Q3 25
$893.8M
Q2 25
$1.2B
Q1 25
$822.1M
Q4 24
$396.9M
Q3 24
$396.7M
Q2 24
$671.1M
Q1 24
$595.9M
Stockholders' Equity
ATRO
ATRO
CTRE
CTRE
Q4 25
$140.1M
$4.0B
Q3 25
$108.9M
$4.0B
Q2 25
$271.6M
$3.3B
Q1 25
$266.8M
$2.9B
Q4 24
$256.1M
$2.9B
Q3 24
$249.2M
$2.4B
Q2 24
$257.9M
$1.9B
Q1 24
$251.7M
$1.7B
Total Assets
ATRO
ATRO
CTRE
CTRE
Q4 25
$706.7M
$5.1B
Q3 25
$682.2M
$5.1B
Q2 25
$646.7M
$4.7B
Q1 25
$662.2M
$3.9B
Q4 24
$648.8M
$3.4B
Q3 24
$651.6M
$2.9B
Q2 24
$644.9M
$2.7B
Q1 24
$630.0M
$2.3B
Debt / Equity
ATRO
ATRO
CTRE
CTRE
Q4 25
0.22×
Q3 25
0.22×
Q2 25
0.35×
Q1 25
0.28×
Q4 24
0.14×
Q3 24
0.16×
Q2 24
0.35×
Q1 24
0.36×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ATRO
ATRO
CTRE
CTRE
Operating Cash FlowLast quarter
$27.6M
$394.0M
Free Cash FlowOCF − Capex
$15.8M
FCF MarginFCF / Revenue
6.6%
Capex IntensityCapex / Revenue
4.9%
Cash ConversionOCF / Net Profit
3.54×
TTM Free Cash FlowTrailing 4 quarters
$43.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ATRO
ATRO
CTRE
CTRE
Q4 25
$27.6M
$394.0M
Q3 25
$34.2M
$100.9M
Q2 25
$-7.6M
$100.8M
Q1 25
$20.6M
$71.4M
Q4 24
$26.4M
$244.3M
Q3 24
$8.4M
$67.2M
Q2 24
$-6.3M
$53.0M
Q1 24
$2.0M
$48.8M
Free Cash Flow
ATRO
ATRO
CTRE
CTRE
Q4 25
$15.8M
Q3 25
$21.0M
Q2 25
$-12.2M
Q1 25
$18.5M
Q4 24
$23.2M
Q3 24
$6.5M
Q2 24
$-8.1M
Q1 24
$439.0K
FCF Margin
ATRO
ATRO
CTRE
CTRE
Q4 25
6.6%
Q3 25
9.9%
Q2 25
-6.0%
Q1 25
9.0%
Q4 24
11.1%
Q3 24
3.2%
Q2 24
-4.1%
Q1 24
0.2%
Capex Intensity
ATRO
ATRO
CTRE
CTRE
Q4 25
4.9%
Q3 25
6.2%
Q2 25
2.2%
Q1 25
1.0%
Q4 24
1.5%
Q3 24
0.9%
Q2 24
0.9%
Q1 24
0.9%
Cash Conversion
ATRO
ATRO
CTRE
CTRE
Q4 25
3.54×
Q3 25
1.35×
Q2 25
-5.81×
1.47×
Q1 25
2.17×
1.08×
Q4 24
4.68×
Q3 24
2.01×
Q2 24
-4.08×
4.92×
Q1 24
1.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ATRO
ATRO

Product Line Electrical Power And Motion$113.8M47%
Product Line Avionics$32.0M13%
Military Aircraft$28.0M12%
General Aviation$22.3M9%
Government And Defense$20.5M9%
Product Line Systems Certification$13.2M6%
Product Line Structures$3.7M2%
Product Line Other$2.3M1%

CTRE
CTRE

Segment breakdown not available.

Related Comparisons